Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/28/22 16:13 | 4/26/22 | SPRO | Health | Drug | Pharmaceutical Preparations | Aquilo Capital Management, LLC | CA | T | P | 208 | 5.24 | 0 | 40 | 1 | 5,321 | I | |||||||||||||||
3/31/22 15:51 | 3/30/22 | SPRO | Health | Drug | Pharmaceutical Preparations | Aquilo Capital Management, LLC | CA | T | P | 439 | 8.79 | 0 | 50 | 1 | 5,282 | I | |||||||||||||||
3/16/22 16:23 | 3/14/22 | SPRO | Health | Drug | Pharmaceutical Preparations | Aquilo Capital Management, LLC | CA | T | P | 181 | 7.63 | 0 | 24 | 0 | 5,232 | I | |||||||||||||||
3/2/22 15:52 | 2/28/22 | SPRO | Health | Drug | Pharmaceutical Preparations | Aquilo Capital Management, LLC | CA | T | P | 427 | 9.53 | 0 | 45 | 1 | 5,208 | I | |||||||||||||||
2/23/22 16:24 | 2/18/22 | SPRO | Health | Drug | Pharmaceutical Preparations | Aquilo Capital Management, LLC | CA | T | P | 137 | 9.24 | 0 | 15 | 0 | 5,163 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |